Comparative Study of Dexmedetomidine, Dexamethasone, and Clonidine Drugs With Ropivacaine in Upper Limb Surgery Under Supraclavicular Brachial Plexus Block.

"A Clinical Comparative Study Of Dexmedetomidine, Dexamethasone And Clonidine As Adjuvants To Local Anaesthetics In Supraclavicular Brachial Plexus Block." - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/01/062007

Enrollment

Registered

2024-01-30

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S525- Fracture of lower end of radius Health Condition 2: S526- Fracture of lower end of ulna Health Condition 3: S523- Fracture of shaft of radius Health Condition 4: S522- Fracture of shaft of ulna Health Condition 5: S521- Fracture of upper end of radius Health Condition 6: S520- Fracture of upper end of ulna Health Condition 7: S518- Open wound of forearm

Interventions

Intervention1: Nil: Nil Control Intervention1: Dexmedetomidine with Lignocaine-Adrenaline To Ropivacaine: Dexmedetomidine (2ml) (1micro/kg) with Lignocaine-Adrenaline (10ml) To Ropivacaine (0.5%) (20m

Eligibility

Inclusion criteria

Inclusion criteria: 90 Patients ASA Grade I and II

Exclusion criteria

Exclusion criteria: History of allergy or any other reaction to local anesthetics Hypertensive patients Renal dysfunction Cardiac disease Bleeding disorder Deranged LFT

Design outcomes

Primary

Measure	Time frame
In The Upper Extremity Surgeries Performed Under Supraclavicular Block Dexmedetomidine is Superior to Clonidine and Dexamethasone due to its Prolonged duration of analgesia, faster onset of action and better quality of sensory and motor blockTimepoint: Baseline	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDR JITENDRA AGRAWAL

Gajra Raja Medical College, Gwalior M.P.

drjagrawal9@gmail.com9300009942

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026